
45
44
Governance Governance
Pacific Assets Trust plc Annual Report for the year ended 31 January 2025 Pacific Assets Trust plc Annual Report for the year ended 31 January 2025
Report of the
Directors
The Directors present this Annual Report on the affairs
of the Company together with the audited financial
statements and the Independent Auditor’s Report for
the year ended 31 January 2025.
Business and Status of the
Company
The Company is registered as a public limited company in
Scotland (Registered Number SC091052) and is an
investment company within the terms of Section 833 of
the Companies Act 2006 (the “Act”). Its shares are
admitted to the closed-ended investment funds category
of the FCA’s Official List and to trading on the main market
of the London Stock Exchange, which is a regulated
market as defined in Section 1173 of the Act.
The Company has been accepted as an investment trust
under Section 1158 of the Corporation Taxes Act 2010
and Part 2 Chapter 1 of Statutory Instrument
2011/2999. This approval relates to accounting periods
commencing on or after 1 February 2012. The Directors
are of the opinion that the Company has conducted its
affairs so as to be able to retain such approval.
It is the Directors’ intention that the Company should
continue to manage its affairs so as to be a qualifying
investment for inclusion in the stocks and shares
components of an Individual Savings Account (“ISA”) and
Junior ISA.
The Company is a member of the Association of
Investment Companies.
Alternative Performance Measures
The financial statements (on pages 66 to 79) set out the
required statutory reporting measures of the Company’s
financial performance. In addition, the Board assesses the
Company’s performance against a range of criteria which are
viewed as particularly relevant for investment trusts. These
measures are summarised on page 1 and explained in greater
detail in the Strategic Report, under the heading ‘Key
Performance Indicators’ on pages 24 and 25. The Directors
believe that these measures enhance the comparability of
information between reporting periods and aid investors in
understanding the Company’s performance.
The measures used for the year under review have
remained consistent with the prior year.
Definitions of the terms used and the basis of their
calculation are set out in the Glossary beginning on
page80.
Annual General Meeting
THE FOLLOWING INFORMATION TO BE DISCUSSED
AT THE FORTHCOMING ANNUAL GENERAL
MEETING IS IMPORTANT AND REQUIRES YOUR
IMMEDIATE ATTENTION.
If you are in any doubt about the action you should
take, you should seek advice from your stockbroker,
bank manager, solicitor, accountant or other financial
adviser authorised under the Financial Services and
Markets Act 2000 (as amended). If you have sold or
transferred all of your ordinary shares in the Company,
you should pass this document, together with any
other accompanying documents, including the form of
proxy, at once to the purchaser or transferee, or to the
stockbroker, bank or other agent through whom the
sale or transfer was effected, for onward transmission
to the purchaser or transferee.
Resolutions relating to the following items of business
will be proposed at the Annual General Meeting to be
held on 1 July 2025.
Resolution 11 Approval of the proposed, amended
Investment Policy
Resolution 12 Authority to allot shares
Resolution 13 Authority to disapply pre-emption rights
Resolution 14 Authority to buy back shares
Resolution 15 Authority to hold General Meetings (other
than the AGM) on at least 14 clear days’ notice
The full text of the resolutions can be found in the Notice
of Annual General Meeting on pages 101 and 102.
Explanatory notes regarding the resolutions can be
found on pages 106 to 108.
Results and Dividend
The results attributable to shareholders for the year are
shown on page 66. Details of the Company’s dividend
record can be found on page 5 and the dividend policy is
outlined in the Strategic Report on page 23.
A final dividend of 4.9p per ordinary share has been
proposed and, subject to shareholder approval, will be paid
on 11 July 2025 to shareholders on the register on 13 June
2025. The associated ex-dividend date is 12 June 2025.
Capital Structure
As at 31 January 2025, there were 120,588,386 ordinary
shares of 12.5p each (“shares”) in issue (2024:
120,958,386). All shares rank equally for dividends and
distributions. Each shareholder is entitled to one vote on a
show of hands and, on a poll, to one vote for every share
held. Details of the substantial shareholders in the
Company are listed on page 47.
At the start of the year under review, the Directors had
shareholder authority to issue up to 12,095,838 shares on
a non-pre-emptive basis and to buy back up to 18,131,662
shares in the market. At the Company’s annual general
meeting held on Tuesday, 9 July 2024, these authorities
expired and new authorities to allot up to 12,095,838
shares (representing 10% of the Company’s issued share
capital) on a non-pre-emptive basis and to buy back up to
18,131,662 shares (representing 14.99% of the
Company’s issued share capital) were granted.
During the year, no new shares were issued (2024:nil).
370,000shares were repurchased and then cancelled
during the year (2024: nil) and there are no shares held in
Treasury.
The powers to issue or buy back the Company’s shares
require the relevant resolution to be passed by
shareholders. Proposals for the renewal of the Board’s
authorities to issue and buy back shares are detailed in
the Notice of AGM beginning on page 101.
There are no restrictions concerning the transfer of
securities in the Company; no special rights with regard
to control attached to securities; no restrictions on
voting rights; no agreements between holders of
securities regarding their transfer known to the
Company; and no agreements which the Company is
party to that might affect its control following a
successful takeover bid.
Financial Instruments
The Company’s financial instruments comprise its
investment portfolio, cash balances, debtors and
creditors which arise directly from its operations such as
sales and purchases awaiting settlement, and accrued
income. The financial risk management objectives and
policies arising from its financial instruments and the
exposure of the Company to risk are disclosed in note 14
to the financial statements, beginning on page 75.
Principal Service Providers
Portfolio Manager
The Company’s investment portfolio has been managed
by Stewart Investors since 1 July 2010. Stewart
Investors are engaged under the terms of aPortfolio
Management Agreement (the “PMA”) effective from
24March 2025, which replaced two previous
agreements.
Under the terms of the PMA, Stewart Investors provide,
inter alia, the following services:
> seeking out and evaluating investment opportunities;
> recommending the manner by which cash should be
invested, divested, retained or realised;
> advising on how rights conferred by the investments
should be exercised;
> analysing the performance of investments made;
> advising the Company in relation to trends, market
movements and other matters which may affect the
investment objective and policy of the Company; and
> marketing and investor relations services.
The PMA is terminable by six months’ notice. Stewart
Investors complied with the terms of the PMA dated
30April 2021 throughout the year to 31January2025.
Stewart Investors are entitled to a fee, paid quarterly, of
0.85% of the Company’s net assets.
Alternative Investment Fund Manager
Frostrow Capital LLP acts as the AIFM. It is an
independent provider of services to the investment
companies sector.
The Board resolved to appoint Frostrow Capital LLP as
the Company’s AIFM with effect from 30 April 2021 on
the terms and subject to the conditions of the alternative
investment fund management agreement between the
Company and Frostrow (the “AIFM Agreement”). The
AIFM Agreement assigns to Frostrow overall
responsibility to manage the Company, subject to the
supervision, review and control of the Board, and
ensures that the relationship between the Company and